HDAC6 and cholangiocarcinoma: Inhibition of HDAC6 restores ciliogenesis and suppresses the proliferation of cancer cells, including glioblastoma (Urdiciain et al., 2019), cholangiocarcinoma (Gradilone et al., 2013), and chondrosarcoma (Xiang et al., 2017).